(Q45767341)

15 December 2017

title

Hepatitis B virus with X gene mutation is associated with the majority of serologically "silent" non-b, non-c chronic hepatitis (English)

1 reference

15 December 2017

1 reference

Fukuda R

1

1 reference

15 December 2017

Ishimura N

2

1 reference

15 December 2017

Kushiyama Y

3

1 reference

15 December 2017

Moriyama N

4

1 reference

15 December 2017

Ishihara S

5

1 reference

15 December 2017

Chowdhury A

6

1 reference

15 December 2017

Tokuda A

7

1 reference

15 December 2017

Sakai S

8

1 reference

15 December 2017

Akagi S

9

1 reference

15 December 2017

Watanabe M

10

1 reference

15 December 2017

Fukumoto S

11

1 reference

15 December 2017

publication date

1 January 1996

1 reference

15 December 2017

Microbiology and Immunology

published in

1 reference

15 December 2017

volume

40

1 reference

15 December 2017

issue

7

1 reference

15 December 2017

page(s)

481-488

1 reference

15 December 2017

Mutation preventing formation of hepatitis B e antigen in patients with chronic hepatitis B infection.

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Hepatitis B X open reading frame deletion mutants isolated from atypical hepatitis B virus infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Cloning and structural analyses of hepatitis B virus DNAs, subtype adr.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Characterization of a functional hepatocyte nuclear factor 3 binding site in the hepatitis B virus nucleocapsid promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Multiple liver-specific factors bind to the hepatitis B virus core/pregenomic promoter: trans-activation and repression by CCAAT/enhancer binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Transcriptional factor C/EBP binds to and transactivates the enhancer element II of the hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

HBV X protein alters the DNA binding specificity of CREB and ATF-2 by protein-protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Detection of antibody against antigen expressed by molecularly cloned hepatitis C virus cDNA: application to diagnosis and blood screening for posttransfusion hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Hepatitis may precede the occurrence of precore region mutation in hepatitis B virus genome during infection in young carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Precore region mutation in hepatitis B virus genome in early stage of infection: a study in hepatitis B e antigen-positive young carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Sequence analysis of hepatitis B virus DNA in immunologically negative infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Detection of a hepatitis B virus variant with a truncated X gene and enhancer II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

An internal domain of the hepatitis B virus X antigen is necessary for transactivating activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Review: hepatitis B virus X-gene product: a promiscuous transcriptional activator

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Biochemical and genetic evidence for the hepatitis B virus replication strategy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Identification of two flavivirus-like genomes in the GB hepatitis agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Isolation of novel virus-like sequences associated with human hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

X protein of hepatitis B virus resembles a serine protease inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Genetic variations of the hepatitis B virus and their clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

"Silent" hepatitis B virus mutants are responsible for non-A, non-B, non-C, non-D, non-E hepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

Complete nucleotide sequences and the characteristics of two hepatitis B virus mutants causing serologically negative acute or chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

A liver-specific enhancer in the core promoter region of human hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1348-0421.1996.TB01098.X

10.1111/J.1348-0421.1996.TB01098.X

21 January 2018

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017